Interferón alfa 2b recombinante más ribavirina en el tratamiento de la hepatitis crónica C Recombinant Interferon alfa-2b plus Ribavirin in treatment of chronic hepatitis C

Interferón alfa 2b recombinante más ribavirina en el tratamiento de la hepatitis crónica C Recombinant Interferon alfa-2b plus Ribavirin in treatment of chronic hepatitis C

El virus de la hepatitis C se ha convertido en la causa principal de hepatitis crónica, cirrosis hepática, hepatocarcinoma, y trasplante de hígado a nivel mundial. OBJETIVO: El presente estudio estuvo dirigido a determinar la evolución virológica, bioquímica e histológica de los pacientes con hepati...

Full description

Bibliographic Details
Main Authors:	Yoan Antonio Sánchez Rodríguez, Enrique Arús Soler, Bienvenido Grá Oramas, Pedro López Saura, Hugo Nodarse Cuní
Format:	Article
Language:	Spanish
Published:	Editorial Ciencias Médicas 2010-06-01
Series:	Revista Cubana de Medicina
Subjects:	Hepatitis crónica C interferón a 2b ribavirina respuesta virológica sostenida Chronic hepatitis C Interferon a 2b Ribavirin sustained virological response
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232010000200002

Similar Items

Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine
by: Yanet Parodis López, et al.
Published: (2005-08-01)

Daily interferon induction regimen using different manufactured interferons (alpha-2a or alpha-2b) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study Esquema de indução diário com interferon alfa 2-a ou alfa 2-b em combinação com ribavirina para tratamento da hepatite crônica C: estudo prospectivo randomizado
by: Eduardo Lorens Braga, et al.
Published: (2006-12-01)

Tratamento de pacientes com hepatite crônica pelo vírus C com interferon-alfa e ribavirina: a experiência da Secretaria de Saúde do Rio Grande do Sul Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil
by: Alexandro Vaesken Alves, et al.
Published: (2003-12-01)

A taxa de resposta sustentada da hepatite C crônica ao tratamento com os diversos interferons-alfa e ribavirinas distribuídos pelo governo brasileiro é semelhante à da literatura mundial The sustained response rates for chronic hepatitis C patients undergoing therapy with the several interferons and ribavarins supplied by Brazilian’s Health Ministry is comparable to those reported in the literature
by: Rafael Nastás Acras, et al.
Published: (2004-03-01)

Tratamiento de la hepatitis crónica por virus C con interferón pegilado cubano y ribavirina
by: Sahilí Corrales Alonso, et al.
Published: (2014-06-01)

Revisión sistemática: Evaluación de la adherencia del tratamiento de pacientes naive con hepatitis C.
by: C. Cano Corral, et al.
Published: (2014-09-01)

Revisión sistemática: Evaluación de la adherencia del tratamiento de pacientes naive con hepatitis C.
by: C. Cano Corral, et al.
Published: (2014-09-01)

Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin Tratamiento con PEG interferón alfa 2b y ribavirina en enfermos previamente tratados con interferón estándar en monoterapia o combinado con ribavirina
by: F. Carnicer, et al.
Published: (2005-05-01)

Tratamiento prolongado con interferón alfa-2b más lamivudina en pacientes con hepatitis crónica B y antígeno e positivo Prolonged treatment with alpha-2b interferon plus lamivudine in patients with e antigen positive chronic hepatitis B
by: Eduardo Vilar Gómez, et al.
Published: (2007-12-01)

Evaluation of Response to Interferon Therapy in Chronic Hepatitis B and Chronic Hepatitis C Patients
by: Hakan LEBLEBİCİOĞLU, et al.
Published: (2001-09-01)

Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)

Interferon convencional versus interferon peguilado associados à ribavirina no tratamento de pacientes coinfectados pelo vírus da hepatite C (genótipo 1) e da imunodeficiência humana Alpha-interferon versus peg-interferon associated to ribavirin in the treatment of genotype 1 hepatitis C virus and human imunodeficiency virus coinfected patients
by: Paulo Roberto Lerias de Almeida, et al.
Published: (2009-06-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

Resultados da terapia dupla (interferon e ribavirina) para hepatite C em um centro de referência no sul do Brasil: um estudo da vida real
by: Fernando Comunello Schacher, et al.
Published: (2016-08-01)

Resultados da terapia dupla (interferon e ribavirina) para hepatite C em um centro de referência no sul do Brasil: um estudo da vida real
by: Fernando Comunello Schacher, et al.
Published: (2016-08-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C Doença celíaca após tratamento de hepatite C crônica com interferon peguilado e ribavirina
by: Elson V. Martins Jr., et al.
Published: (2004-06-01)

Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?
by: Giovanni Faria Silva, et al.

Pityriasis Rosea Associated with Pegylated Interferon Alfa and Ribavirin Treatment in a Patient with Chronic Hepatitis C
by: Rahmet Güner, et al.
Published: (2013-06-01)

Response factors to pegylated interferon-alfa/ribavirin treatment in chronic hepatitis C patients genotype 1b
by: Jovanović-Ćupić Snežana, et al.
Published: (2014-01-01)

An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon® plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients
by: Marlen I Castellanos-Fernández, et al.

Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection Neumonitis intersticial secundaria a tratamiento con interferón pegilado
by: J. Torres Macho, et al.
Published: (2010-10-01)

Hepatitis B, interferon, and acne fulminans in a young girl
by: Sandeep Arora, et al.
Published: (2016-01-01)

Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C Oscilaciones de la ferritina sérica asociadas al tratamiento antiviral en la hepatitis crónica por virus C
by: J. M. Ladero, et al.
Published: (2009-01-01)

Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
by: M.H.P. Pavan, et al.

Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controls viral replication in genotype-1 patients with chronic hepatitis C La respuesta inmune T1 inducida durante el tratamiento con PEG-IFNα mαs ribavirina controla la replicaciσn viral en pacientes con hepatitis crónica C
by: M. Trapero, et al.
Published: (2005-07-01)

El interferón en el tratamiento de la hepatitis C crónica Inmunobiología básica e inmunopatología del hígado Interferon treatment of chronic hepatitis C: Basic immunobiology and immunopathology of the liver
by: J.S. Mazana
Published: (2013-06-01)

Revisão sistemática da eficácia do interferon alfa (convencional, peguilado) e lamivudina para o tratamento da hepatite crônica B Efficacy of interferon (conventional, pegylated) and lamivudine for treatment of chronic hepatitis B: a systematic review
by: Alessandra Maciel Almeida, et al.
Published: (2009-08-01)

Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil
by: Marcelo Cunio Machado Fonseca, et al.

Resposta sustentada após 1 ano de interferon isolado ou associado a ribavirina em pacientes com cirrose pelo vírus C
by: Hugo Cheinquer, et al.
Published: (2022-06-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.

Five-year follow-up of patients with chronic C hepatitis and sustained virological response Seguimiento a 5 años de pacientes con hepatitis crónica C y respuesta viral sostenida
by: I. Puig-del-Castillo, et al.
Published: (2011-02-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Unusual course of interferon-related retinopathy in chronic hepatitis C
by: Gaurav Mathur, et al.
Published: (2016-01-01)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
by: Yi-Wen Huang, et al.
Published: (2022-05-01)

INTERFERON-FREE THERAPY FOR HEPATITIS C IN PAKISTAN
by: Dure Nayab, et al.
Published: (2017-03-01)

Interferons and hepatitis C virus
by: Markus H. Heim
Published: (2012-05-01)

Gender influence on treatment of chronic hepatitis C genotype 1 Influência do gênero no tratamento da hepatite C crônica genótipo 1
by: Janaína Luz Narciso-Schiavon, et al.
Published: (2010-06-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)